FDA Inspection 1166238 — Sea Pearl East Inc.
The FDA completed an inspection of Sea Pearl East Inc. on Mar 24, 2022 in Glen Rock, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 24, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Glen Rock, NJ (United States)